Valeo Financial Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.1M | Buy |
47,980
+2,473
| +5% | +$532K | 0.25% | 42 |
|
|
2026
Q1 | $9.9M | Sell |
45,507
-7,727
| -15% | -$1.71M | 0.24% | 46 |
|
|
2025
Q4 | $12.2M | Buy |
53,234
+745
| +1% | +$170K | 0.27% | 44 |
|
|
2025
Q3 | $12.2M | Sell |
52,489
-796
| -1% | -$162K | 0.28% | 41 |
|
|
2025
Q2 | $9.89M | Sell |
53,285
-29,989
| -36% | -$5.57M | 0.24% | 48 |
|
|
2025
Q1 | $10.2M | Buy |
83,274
+1,529
| +2% | +$297K | 0.28% | 42 |
|
|
2024
Q4 | $8.36M | Buy |
81,745
+1,255
| +2% | +$231K | 0.23% | 48 |
|
|
2024
Q3 | $9.04M | Buy |
80,490
+437
| +0.5% | +$81.6K | 0.26% | 48 |
|
|
2024
Q2 | $7.78M | Sell |
80,053
-679
| -0.8% | -$112K | 0.24% | 50 |
|
|
2024
Q1 | $7.73M | Buy |
80,732
+2,013
| +3% | +$347K | 0.28% | 46 |
|
|
2023
Q4 | $6.82M | Sell |
78,719
-713
| -0.9% | -$104K | 0.28% | 51 |
|
|
2023
Q3 | $6.67M | Buy |
79,432
+2,789
| +4% | +$409K | 0.3% | 46 |
|
|
2023
Q2 | $5.66M | Buy |
76,643
+1,996
| +3% | +$293K | 0.26% | 52 |
|
|
2023
Q1 | $6.37M | Buy |
74,647
+2,579
| +4% | +$394K | 0.31% | 48 |
|
|
2022
Q4 | $6.04M | Sell |
72,068
-877
| -1% | -$134K | 0.33% | 45 |
|
|
2022
Q3 | $5.14M | Buy |
72,945
+3,443
| +5% | +$494K | 0.33% | 43 |
|
|
2022
Q2 | $5.33M | Sell |
69,502
-11,773
| -14% | -$1.8M | 0.33% | 49 |
|
|
2022
Q1 | $7.55M | Sell |
81,275
-149
| -0.2% | -$21.6K | 0.38% | 37 |
|
|
2021
Q4 | $6.33M | Buy |
81,424
+16
| +0% | +$1.89K | 0.34% | 40 |
|
|
2021
Q3 | $5.05M | Buy |
81,408
+5,983
| +8% | +$684K | 0.29% | 54 |
|
|
2021
Q2 | $4.6M | Sell |
75,425
-657
| -0.9% | -$74K | 0.28% | 57 |
|
|
2021
Q1 | $4.49M | Sell |
76,082
-22,155
| -23% | -$2.37M | 0.21% | 62 |
|
|
2020
Q4 | $4.08M | Buy |
98,237
+65,915
| +204% | +$6.33M | 0.21% | 61 |
|
|
2020
Q3 | $2.83M | Buy |
32,322
+196
| +0.6% | +$18.5K | 0.25% | 61 |
|
|
2020
Q2 | $3.15M | Buy |
32,126
+3,128
| +11% | +$275K | 0.29% | 51 |
|
|
2020
Q1 | $2.31M | Buy |
28,998
+2,305
| +9% | +$196K | 0.25% | 63 |
|
|
2019
Q4 | $2.36M | Buy |
26,693
+9,453
| +55% | +$785K | 0.23% | 68 |
|
|
2019
Q3 | $1.3M | Buy |
17,240
+2,471
| +17% | +$169K | 0.14% | 92 |
|
|
2019
Q2 | $1.07M | Buy |
14,769
+3,433
| +30% | +$270K | 0.12% | 124 |
|
|
2019
Q1 | $914K | Buy |
11,336
+60
| +0.5% | +$4.91K | 0.11% | 133 |
|
|
2018
Q4 | $1.04M | Sell |
11,276
-369
| -3% | -$32.5K | 0.15% | 107 |
|
|
2018
Q3 | $912K | Sell |
11,645
-563
| -5% | -$53.4K | 0.12% | 127 |
|
|
2018
Q2 | $1.18M | Buy |
12,208
+592
| +5% | +$57.8K | 0.17% | 99 |
|
|
2018
Q1 | $1.1M | Buy |
11,616
+2,582
| +29% | +$284K | 0.18% | 98 |
|
|
2017
Q4 | $874K | Sell |
9,034
-2,093
| -19% | -$197K | 0.14% | 109 |
|
|
2017
Q3 | $989K | Buy |
+11,127
| New | +$847K | 0.22% | 89 |
|
Other funds holding ABBV
Valeo Financial Advisors's ABBV Position: Q2 2026 in Review
Valeo Financial Advisors increased its AbbVie (ABBV) stake by 5.4% in Q2 2026, buying an estimated $532K and bringing the position to 47,980 shares worth $12.1M. The position accounts for 0.25% of the portfolio, ranked #42.
Valeo Financial Advisors first reported a position in ABBV in Q3 2017 and has held it in 36 quarters since. The position peaked at $12.2M in Q4 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Valeo Financial Advisors held 47,980 shares of AbbVie worth $12.1M as of Q2 2026.
- Valeo Financial Advisors bought 2,473 AbbVie shares in Q2 2026, an estimated $532K.
- AbbVie made up 0.25% of Valeo Financial Advisors's portfolio in Q2 2026, its #42 holding.
- Valeo Financial Advisors first reported a position in AbbVie in Q3 2017 and has held it in 36 quarters since.
- Valeo Financial Advisors's AbbVie position peaked at $12.2M in Q4 2025.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Valeo Financial Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.